News

Current | 2007

Lions Capital Increases Investment in Protox Therapeutics

Vancouver, BC, October 31, 200 - Lions Capital Corp. announced today that it has made an additional investment in Protox Therapeutics on behalf of two of its funds under management - BC Advantage Funds (VCC) Ltd. and the Pender NDI Life Sciences Fund (VCC) Inc. doing business as the Advantage Life Science Fund II... read more

Lions Capital Closes Acquisition of Pender NDI Life Sciences Fund

Vancouver, BC, October 15, 2007 - Lions Capital Corp. announced today that its previously announced acquisition of the fund management agreement for Pender NDI Life Science Fund (VCC) Inc. has closed. Lions Capital will rename Pender NDI as the Advantage Life Science Fund II... read more

OCT 03 2007
Lions Capital Acquires Pender NDI Life Sciences Fund
Vancouver, BC, October 3, 2007 - Lions Capital Corp. announced today that it has agreed to acquire the fund management agreement for Pender NDI Life Sciences Fund (Pender NDI) from NDI Investment Management Inc. (NDII) and Pender Fund Capital Management Ltd., a wholly owned subsidiary of Pender Financial Group Corp. (TSX-V: PDF)... read more